Catalyst Wire Dossier Catalyst Wire Dossier

bilastine ophthalmic solution 0.6%

bilastine · Faes Farma, S.A.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for bilastine ophthalmic solution 0.6%, covering 2021-12-14 to 2023-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children [Phase 3]

See pricing